BioPharma Dive July 3, 2023
U.S. life sciences companies that conduct trials in Europe must deal with more than language nuances and time-zone differences. They must also comply with the General Data Protection Regulation (GDPR). This bedrock privacy regulation controls the use of all personal data, not just health data, of persons residing in the EU and the UK. And thanks to its extraterritorial scope, it applies to U.S. trial sponsors, even if they don’t have offices in the EU and the UK.
In this article, we’ll discuss what the GDPR is and why it matters to your life sciences company. We’ll also show you how iliomad Health Data can help you maintain GDPR compliance.
A Brief Overview of the GDPR
The EU adopted the...